Growth Metrics

Merck (MRK) Dividends Paid - Common Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.06%
Dec 31, 2025 5.53%
Sep 30, 2025 5.62%
Jun 30, 2025 5.66%
Mar 31, 2025 5.74%
Dec 31, 2024 6.79%
Sep 30, 2024 6.98%
Jun 30, 2024 6.23%
Mar 31, 2024 6.43%
Dec 31, 2023 7.72%
Sep 30, 2023 7.62%
Jun 30, 2023 7.53%
Mar 31, 2023 7.36%
Dec 31, 2022 6.41%
Sep 30, 2022 6.37%
Jun 30, 2022 6.25%
Mar 31, 2022 6.16%
Dec 31, 2021 5.27%
Sep 30, 2021 5.30%
Jun 30, 2021 5.17%
Mar 31, 2021 5.16%
Dec 31, 2020 4.07%
Sep 30, 2020 3.97%
Jun 30, 2020 3.91%
Mar 31, 2020 3.92%
Dec 31, 2019 2.22%
Sep 30, 2019 1.69%
Jun 30, 2019 1.86%
Mar 31, 2019 2.05%
Dec 31, 2018 0.27%
Sep 30, 2018 0.41%
Jun 30, 2018 -0.32%
Mar 31, 2018 -0.11%
Dec 31, 2017 18.59%
Sep 30, 2017 0.09%
Jun 30, 2017 0.42%
Mar 31, 2017 0.23%
Dec 31, 2016 18.87%
Sep 30, 2016 1.63%
Jun 30, 2016 2.03%
Mar 31, 2016 1.71%
Dec 31, 2015 18.81%
Sep 30, 2015 1.50%
Jun 30, 2015 1.83%
Mar 31, 2015 1.49%
Dec 31, 2014 9.38%
Sep 30, 2014 9.78%
Jun 30, 2014 10.76%
Mar 31, 2014 9.93%